{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7223,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "team_bio",
      "function": "other",
      "notes": "This is a character bio slide for a film or series pitch.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/6",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 6,
          "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Call to Adventure",
          "beatSlug": "heros-journey-call-to-adventure",
          "evidence": "The team bios could be seen as assembling the team for the adventure.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide presents a character archetype, likely for a film or creative project pitch.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/7",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 6,
          "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Call to Adventure",
          "beatSlug": "heros-journey-call-to-adventure",
          "evidence": "The team bios could be seen as assembling the team for the adventure.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "team_bio",
      "function": "other",
      "notes": "Slide describes a fictional character and the actress portraying her.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/8",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 6,
          "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Call to Adventure",
          "beatSlug": "heros-journey-call-to-adventure",
          "evidence": "The team bios could be seen as assembling the team for the adventure.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide introduces a character named Mr. Endo, played by Ken'ichi Endo, describing his role as the owner of DoggieMart.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/9",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 6,
          "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Call to Adventure",
          "beatSlug": "heros-journey-call-to-adventure",
          "evidence": "The team bios could be seen as assembling the team for the adventure.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide presents character bios for a film or project, featuring headshots and scene stills.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/10",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 6,
          "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Call to Adventure",
          "beatSlug": "heros-journey-call-to-adventure",
          "evidence": "The team bios could be seen as assembling the team for the adventure.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide is split into two distinct sections: a character bio for Jared (played by Adam Hagenbuch) and a visual collage of celebrity animals.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/11",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 6,
          "beatId": "ee4f824f-4bd2-4257-9a0d-4ac6023cc1d2",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Call to Adventure",
          "beatSlug": "heros-journey-call-to-adventure",
          "evidence": "The team bios could be seen as assembling the team for the adventure.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "other",
      "function": "establish_context",
      "notes": "Uses paw print icons as bullet points.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/12",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 12,
          "beatId": "a7c7c48d-6147-4b5b-a88f-84cd050dfa91",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "Narrative styles and successful movies in related genres highlight the need for their project.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "other",
      "function": "establish_context",
      "notes": "The slide uses a comparative approach to validate the commercial viability of specific tropes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/13",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 12,
          "beatId": "a7c7c48d-6147-4b5b-a88f-84cd050dfa91",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "Narrative styles and successful movies in related genres highlight the need for their project.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/14",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 12,
          "beatId": "a7c7c48d-6147-4b5b-a88f-84cd050dfa91",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "Narrative styles and successful movies in related genres highlight the need for their project.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/15",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 15,
          "beatId": "65ba646a-c3d7-484c-a696-291af6d4c0a6",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The production timeline offers a sense of progression and nearing completion.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "timeline",
      "function": "plan_implementation",
      "notes": "The timeline uses a diagonal layout with numbered steps.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/16",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 15,
          "beatId": "65ba646a-c3d7-484c-a696-291af6d4c0a6",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The production timeline offers a sense of progression and nearing completion.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e29f-7298-83f4-f399e710dc49",
      "docSlug": "23480e67a083cbde563694d24fd9cdc8",
      "documentTitle": "AKT Pictures | Other Presentation Deck | 17 slides",
      "authorId": "akt-pictures",
      "authorName": null,
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": "The slide features the project title 'when I was a human' and a stylized graphic of a person and a dog shadow.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e29f-7298-83f4-f399e710dc49/17",
      "deckHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49",
      "deckAnchorHref": "/decks/019de075-e29f-7298-83f4-f399e710dc49#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 17,
          "beatId": "bc7b36d6-1de7-40f6-b9df-67063f2b1759",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The closing ask prompts action from the investors.",
          "position": 5,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/4SGQR6LqaMYx9lmNosII2IL4r74MTSKu5uyFcFWKfiA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNWVkNjBjNGNjODVhMDk0ZGJhZTJmYTEzY2IyNmEzNC9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/1",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/ozrFYpR23ySjHPbVUKULzPdzzIz9qD6yuNpQLUxpGKs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNWVkNjBjNGNjODVhMDk0ZGJhZTJmYTEzY2IyNmEzNC9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/_QR5pTvshvOA8iSYsmPlNgeg78nGCopNLw0LjHyTLbI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNWVkNjBjNGNjODVhMDk0ZGJhZTJmYTEzY2IyNmEzNC9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/QNC8HVEToQt97BnYFGzQ-IBoFbLNHuN1zhYBg_hsWjw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNWVkNjBjNGNjODVhMDk0ZGJhZTJmYTEzY2IyNmEzNC9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/2",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "agenda",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/3",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/4",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses a numbered list format to present five key highlights about the company's spin-off status, cytokine portfolio, and specific drug program progress.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/5",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style chart to map drug development stages across different indications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/6",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "team_bio",
      "function": "introduce_nominees",
      "notes": "The slide lists names, titles, and previous company affiliations for both the Board and Management Team.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/7",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The diagram illustrates the interaction between T cells, tumor cells, and cytokines (IL-2, IL-12, IL-18) and the mechanism of checkpoint inhibitors.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/8",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-8",
      "loopMatches": [
        {
          "to": 9,
          "from": 8,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b9e35abb-b37b-4734-a4e7-f370e28be28e",
          "evidence": "Slides 8-9 imply that current therapies have limitations and that Mural Oncology's solutions are needed.",
          "position": 0,
          "objective": "What are the consequences of not addressing the limitations of current cytokine therapies?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 8,
          "beatId": "3ac1c689-f5a4-4697-9836-72c6ac79bd59",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 8-9 discuss the role of cytokines in immuno-oncology and their limitations.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "key_messages",
      "function": "present_framework",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/9",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-9",
      "loopMatches": [
        {
          "to": 9,
          "from": 8,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b9e35abb-b37b-4734-a4e7-f370e28be28e",
          "evidence": "Slides 8-9 imply that current therapies have limitations and that Mural Oncology's solutions are needed.",
          "position": 0,
          "objective": "What are the consequences of not addressing the limitations of current cytokine therapies?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 8,
          "beatId": "3ac1c689-f5a4-4697-9836-72c6ac79bd59",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 8-9 discuss the role of cytokines in immuno-oncology and their limitations.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "comparison_table",
      "function": "present_solution",
      "notes": "The slide uses a problem-solution framework to justify the engineering approach for each therapeutic program.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/10",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/11",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "roadmap",
      "function": "present_framework",
      "notes": "Uses a vertical process flow diagram to represent development stage gates.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/12",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "Uses a before-after-framing style comparison to illustrate the mechanism of action differentiation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/13",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The chart displays longitudinal data for three cell types over 35 days, highlighting the differential pharmacodynamic response.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/14",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "comparison_table",
      "function": "present_framework",
      "notes": "The table uses a structured approach to categorize clinical trials into Foundational, Alternative Dosing, and Registrational enabling.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/15",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide uses a process flow diagram to illustrate the progression of the clinical trial cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/16",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide presents clinical trial safety data (ARTISTRY-1) comparing monotherapy and combination therapy cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/17",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a human body diagram to map clinical responses (CR, PR, uPR) by tumor type and treatment regimen.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/18",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}